Cobiz Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-42,330
Closed -$2.88M 134
2017
Q1
$2.88M Sell
42,330
-1,109
-3% -$78K 0.64% 58
2016
Q4
$3.11M Sell
43,439
-120
-0.3% -$8.92K 0.73% 58
2016
Q3
$3.45M Sell
43,559
-267
-0.6% -$21.7K 0.83% 53
2016
Q2
$3.66M Sell
43,826
-2,345
-5% -$208K 0.92% 49
2016
Q1
$4.24M Sell
46,171
-1,824
-4% -$164K 1.04% 43
2015
Q4
$4.86M Sell
47,995
-375
-0.8% -$39K 1.15% 33
2015
Q3
$4.75M Sell
48,370
-17,612
-27% -$1.96M 1.15% 37
2015
Q2
$7.72M Sell
65,982
-2,442
-4% -$267K 1.73% 11
2015
Q1
$6.71M Sell
68,424
-880
-1% -$89.4K 1.5% 21
2014
Q4
$6.53M Sell
69,304
-742
-1% -$76.7K 1.49% 22
2014
Q3
$7.46M Sell
70,046
-2,003
-3% -$196K 1.74% 13
2014
Q2
$5.97M Sell
72,049
-133
-0.2% -$10.4K 1.38% 32
2014
Q1
$5.12M Buy
72,182
+22,869
+46% +$1.79M 1.22% 42
2013
Q4
$3.7M Buy
+49,313
New +$3.43M 0.88% 55
2013
Q3
Sell
-134
Closed -$7K 208
2013
Q2
$7K Buy
+134
New +$6.99K ﹤0.01% 301

Other funds holding GILD

Cobiz Wealth's GILD Position: Q2 2017 in Review

Cobiz Wealth sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 42,330 shares — an estimated $2.88M sold.

Cobiz Wealth first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $7.72M in Q2 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Cobiz Wealth reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Cobiz Wealth sold 42,330 Gilead Sciences shares in Q2 2017, an estimated $2.88M.
  • Cobiz Wealth first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
  • Cobiz Wealth's Gilead Sciences position peaked at $7.72M in Q2 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Cobiz Wealth's 13F filing for Q2 2017, filed 11 Jul 2017.